Histone deacetylase inhibition attenuates cell growth with associated telomerase inhibition in high-grade childhood brain tumor cells

Molecular Cancer Therapeutics
Ruman RahmanRichard G Grundy

Abstract

Aberrant epigenetic regulation of gene expression contributes to tumor initiation and progression. Studies from a plethora of hematologic and solid tumors support the use of histone deacetylase inhibitors (HDACi) as potent anticancer agents. However, the mechanism of HDACi action with respect to the temporal order of induced cellular events is unclear. The present study investigates the anticancer effects of the HDACi trichostatin A in high-grade childhood brain tumor cells. Acute exposure to trichostatin A resulted in marked inhibition of cell proliferation, an increase in the proportion of G(2)-M cells, activation of H2A.X, and subsequent induction of apoptosis in the majority of cell lines. These phenotypic effects were associated with abrogation of telomerase activity and human telomerase reverse transcriptase downregulation in the majority of cell lines. In contrast, no cytotoxicity was observed in primary ependymal cells with respect to cilia function. Thus, inhibition of histone deacetylases leads to antiproliferative and proapoptotic effects in childhood brain tumor cells, likely to involve altered chromatin regulation at the human telomerase reverse transcriptase promoter.

References

Dec 17, 1994·BMJ : British Medical Journal·C A Stiller
Feb 13, 1999·Nature Genetics·K J WuR Dalla-Favera
Sep 24, 1999·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·B WagenknechtM Weller
Sep 15, 2000·The Journal of Biological Chemistry·Y S Cong, S Bacchetti
Jan 25, 2002·International Journal of Cancer. Journal International Du Cancer·Mitsuhiro SuenagaShigeru Kohno
Feb 8, 2002·Cell·Ricky W JohnstoneScott W Lowe
Jul 18, 2002·Nature Reviews. Drug Discovery·Ricky W Johnstone
Jan 18, 2003·Blood·Nicholas MitsiadesKenneth C Anderson
Feb 11, 2004·Neuro-oncology·Domenico DidianoMichael A Grotzer
Apr 20, 2004·FEBS Letters·Ralf Janknecht
May 18, 2004·Cancer Cell·Ping ZhuMartin Göttlicher
Dec 4, 2004·International Journal of Cancer. Journal International Du Cancer·Kevin CamphausenPhilip J Tofilon
Jan 7, 2005·The Journal of Pharmacology and Experimental Therapeutics·Jim J XiaoKenneth K Chan
Aug 12, 2005·Molecular Cancer Therapeutics·Pilar García-MoralesMiguel Saceda
Jan 7, 2006·Nature Reviews. Cancer·Saverio Minucci, Pier Giuseppe Pelicci
Feb 10, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·In Ah KimGary D Kao
Feb 10, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dong YinH Phillip Koeffler
Jul 24, 2007·The Lancet Oncology·Sophie WilneDavid Walker
Oct 24, 2007·Molecular Cancer Research : MCR·Milos DokmanovicPaul A Marks
Feb 8, 2008·Nature Reviews. Cancer·Calvin B Harley
Aug 15, 2008·Neuro-oncology·Lee RidleyUNKNOWN Children's Cancer and Leukaemia Group Biological Studies Committee
Sep 6, 2008·The International Journal of Biochemistry & Cell Biology·Gaetano Gargiulo, Saverio Minucci
Oct 28, 2008·Journal of Child Neurology·Roger J Packer
Feb 3, 2009·Cancer Letters·Victoria M RichonJames S Hardwick
Mar 25, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Evanthia GalanisJan C Buckner
Apr 4, 2009·Cancer Letters·Marc BuchwaldThorsten Heinzel

❮ Previous
Next ❯

Citations

Dec 12, 2012·Current Oncology Reports·Emma B Holliday, Erik P Sulman
Apr 26, 2013·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·J-H KimJ P Greenfield
Sep 6, 2011·Current Opinion in Oncology·Jacques GrillCéline Ferreira
Jul 24, 2014·CNS Oncology·Jonas EckerTill Milde
Feb 26, 2013·Brain Pathology·Stephen C MackMichael D Taylor
Jun 15, 2011·International Journal of Cancer. Journal International Du Cancer·Ruman Rahman, Richard Grundy
May 10, 2012·Brain Pathology·Till MildeAndrey Korshunov
Jul 2, 2015·World Journal of Microbiology & Biotechnology·Kalarikkal Gopikrishnan KiranJayaraman Angayarkanni
Apr 28, 2016·Pharmacology & Therapeutics·Yinnan Chen, Yanmin Zhang
Mar 30, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ajay KumarNilesh Kumar Sharma
Jan 1, 2011·Cancers·Irfan A Qureshi, Mark F Mehler
Jul 31, 2019·Medicinal Research Reviews·Xing ChenXin-Hua Liu
Jun 11, 2014·Molecular Medicine Reports·Lei QiuZuoquan Chen
Apr 4, 2021·Cancers·Fatma Dogan, Nicholas R Forsyth

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.